Dr. Javier Alfaro received his Master’s degree in Biochemistry at Dalhousie University (Canada), specialising in evolutionary bioinformatics. He pursued his doctoral studies at the University of Toronto where he was eventually conferred the PhD degree in Medical Biophysics. He is currently leading the Computational Sciences Group at the International Centre for Cancer Vaccine Science. He also manages the Polish team within the international consortium implementing the KATY project as part of the Horizon 2020 programme, its purpose being to develop tools, based on AI mechanisms, to diagnose kidney cancer.

THE SCOPE OF THE RESEARCH

The research objective of Dr. Alfaro’s team is to develop, using computational methods, a set of tools to support modulation of the patient’s immune system activity with the aim of increasing the effectiveness of applied therapies. The team’s principal scientific interest is to foster the development of new immuno-oncology strategies and to make them precisely tailored to patient groups. Once developed, the tools will be used in designing therapeutic vaccines to treat immune system dysfunctions such as autoimmune and oncologic diseases.